Recombinant Human Interferon a2a exerts broad-spectrum antitumor, antiviral and immuno-regulatory activities. By binding to specific receptors on the cell surface, it can induce the production of antiviral protein that can inhibit the replication of viruses in host cells, improve the immune response by enhancing the phagocytose of phagocytes, cytotoxicity of lymphocyte and the function of natural killer cells.

Indications:
1.Lymphatic or haemopoietic tumor: Hairy cell leukemia, multiple myeloma, non-Hodgkin’s lymphoma, chronic myeloid leukemia
2.Viral disease:
Chronic hepatitis B patients with indicators such as positive HBV-DNA, positive DNA polymerase and positive HBeAg;
Acute and chronic hepatitis C patients with indicators such as positive HCV antibody, elevated serum alanine aminotransferase (ALT) and without compensated liver disease (Child class A)
condylomata acuminata